Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
Rhea-AI Summary
Viatris (Nasdaq: VTRS) announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026. Company executives will host a conference call and live webcast at 8:30 a.m. ET the same day, accessible via investor.viatris.com and dedicated phone lines.
Positive
- None.
Negative
- None.
News Market Reaction – VTRS
In the Jul 1 session, VTRS gained 1.89%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 13 | Earnings date notice | Neutral | +2.7% | Set timing and access details for Q1 2026 results webcast. |
| Feb 03 | Earnings date notice | Neutral | +5.0% | Announced Q4/FY 2025 results date and separate March 19 investor event. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings date announcements for VTRS have historically been followed by moderately positive single-day moves.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-second-quarter-2026-financial-results-on-august-6-2026-302814993.html
SOURCE Viatris Inc.